Dimensional Fund Advisors LP Cytosorbents Corp Transaction History

Dimensional Fund Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$1.08 - $1.94 $24,719 - $44,402	-22,888 Reduced 28.81%	56,570 $62,000
Q3 2023 Nov 09, 2023	SELL	$1.86 - $4.03 $12,197 - $26,428	-6,558 Reduced 7.62%	79,458 $149,000
Q1 2023 May 12, 2023	SELL	$1.79 - $4.17 $13,000 - $30,286	-7,263 Reduced 7.79%	86,016 $289,000
Q4 2022 Feb 09, 2023	SELL	$1.03 - $1.63 $16,851 - $26,668	-16,361 Reduced 14.92%	93,279 $144,000
Q3 2022 Nov 10, 2022	SELL	$1.39 - $2.46 $105,624 - $186,932	-75,989 Reduced 40.94%	109,640 $149,000

Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $104,387 - $190,981	-59,311 Reduced 24.21%	185,629 $407,000
Q1 2022 May 13, 2022	SELL	$2.88 - $4.23 $13,636 - $20,029	-4,735 Reduced 1.9%	244,940 $781,000
Q4 2021 Feb 09, 2022	BUY	$4.05 - $8.11 $108,616 - $217,502	26,819 Added 12.03%	249,675 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $1.13 Million - $1.57 Million	161,369 Added 262.44%	222,856 $1.81 Million
Q2 2021 Aug 12, 2021	BUY	$7.55 - $9.42 $464,226 - $579,207	61,487 New	61,487 $464,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.